Accessibility Menu
Oxford Nanopore Technologies Plc logo

Oxford Nanopore Technologies Plc(OTC) ONTTF

Market Cap$1.50BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-82%
5 YearN/A
1 Year-43%
1 Month-9%
$1.54
+4.05%
+0.06Today
Oxford Nanopore Technologies Plc last closing stock price
MetricPriceDate
Last closeUSD 1.542026-07-31
Oxford Nanopore Technologies Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.62%USD 1.472026-07-24
1 month-9.41%USD 1.702026-07-01
3 month-12%USD 1.752026-05-01
Year to date-10.47%USD 1.722025-12-31
1 year-43.17%USD 2.712025-07-31
3 year-53.9%USD 3.342023-08-01
Since inception-82.02%USD 8.572021-10-15

Oxford Nanopore Technologies Plc Financials at a Glance

Market Cap

$1.50BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£407.05M

Net Income (TTM)

-£291.36M

EPS (TTM)

-$0.20

P/E Ratio

-7.73

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.54

Volume

5,423

Open

$1.54

Previous Close

$1.54

Daily Range

$1.50 - $1.54

52-Week Range

$1.27 - $3.19

Estimated Earnings Date

Aug 19, 2026

ONTTF News

Medical-gloved hand holding human DNA in front of sequence imaging.jpg

4 Best Genetic Sequencing Stocks for 2026 and How to Invest

Keith SpeightsJul 13, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc is a pioneering biotechnology company focused on developing and commercializing innovative nanopore-based sensing technology. This technology enables the analysis of various types of molecules, including DNA and RNA, through a range of advanced sequencing devices.

Products and Services
  • MinION: A portable device for DNA and RNA sequencing
  • GridION: A benchtop instrument for analyzing multiple flow cells
  • EPI2ME: A cloud-based platform for real-time data analysis
Growth Outlook
  • Recent quarterly revenue reached £118.3 million, showing strong demand
  • Continued investment in R&D, with £53.6 million allocated last quarter
  • Expansion of product offerings, including new devices like MinION Mk1D
Financial Highlights
  • Trailing twelve months revenue of £405.5 million, indicating growth potential
  • Current ratio of 3.56, reflecting strong liquidity position
  • Net income for the latest quarter was -£73.4 million, highlighting ongoing investment in growth
Oxford Nanopore Technologies plc stands out in the biotechnology sector with its unique approach to molecular analysis. The company's diverse product line, including portable and benchtop sequencers, caters to a wide range of applications in genomics and diagnostics. The recent quarterly revenue demonstrates robust market demand, while significant investments in research and development signal a commitment to innovation. The strong liquidity position, as indicated by the current ratio, provides a solid foundation for future growth. Despite recent net losses, the ongoing expansion of product offerings and technological advancements position Oxford Nanopore as a key player in the rapidly evolving biotechnology landscape.
AI Generated • Jul 22, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

1,403

CEO

Gordon Sanghera, PhD

Website

nanoporetech.com

Headquarters

Oxford, OXF OX4 4DQ, GB

ONTTF Financials

Key Financial Metrics (TTM)

Gross Margin

58.64%

Operating Margin

-69.36%

Net Income Margin

-64.85%

Return on Equity

-29.43%

Return on Capital

-25.42%

Return on Assets

-23.33%

Earnings Yield

-12.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.50BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

975.25M

Volume

5.42K

Avg. Volume

37.76K

Financials (TTM)

Gross Profit

£236.67M

Operating Income

-£307.61M

EBITDA

-£228.26M

Operating Cash Flow

-£176.81M

Capital Expenditure

-£52.14M

Free Cash Flow

-£229.02M

Cash & ST Invst.

£255.26M

Total Debt

£41.49M

Oxford Nanopore Technologies Plc Performance Analysis

Oxford Nanopore Technologies Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 244,635,23933.1%
20232023-12-31GBP 210,906,120-13.8%
20242024-12-31GBP 234,083,71511.0%
20252025-12-31GBP 295,075,62926.1%
Oxford Nanopore Technologies Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-300.5%
Q42024-12-3117.9%
Q22025-06-306.5%
Q42025-12-3112.0%
Oxford Nanopore Technologies Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.14-51.5%
20232023-12-31GBP -0.2369.2%
20242024-12-31GBP -0.21-9.6%
20252025-12-31GBP -0.20-4.3%
Oxford Nanopore Technologies Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3013.4%
Q42024-12-3111.5%
Q22025-06-302.2%
Q42025-12-31-0.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£118.26M

+41.4%

Gross Profit

£69.88M

+70.7%

Gross Margin

59.09%

N/A

Market Cap

$1.50BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.07M

N/A

Employees

1,403

N/A

Net Income

-£73.38M

+13.1%

EBITDA

-£39.28M

+45.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£255.26M

-5.5%

Total Debt

£41.49M

-0.4%

Accounts Receivable

£66.59M

+57.3%

Inventory

£81.49M

-19.8%

Long Term Debt

£36.29M

-2.8%

Short Term Debt

£5.20M

+20.3%

Return on Assets

-23.33%

N/A

Return on Invested Capital

-30.78%

N/A

Free Cash Flow

-£19.70M

+76.3%

Operating Cash Flow

-£18.60M

+76.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PHMMFPharma Mar, S.A.
$86.09+0.00%
GENSFGenus plc
$31.07+0.00%
MEOBFMesoblast Limited
$1.70+0.00%
ZRSEFDocMorris AG
$10.24+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About ONTTF

What is the current price of Oxford Nanopore Technologies Plc?

Oxford Nanopore Technologies Plc is trading at $1.54 per share.

What is the 52-week range for Oxford Nanopore Technologies Plc?

Over the past 52 weeks, Oxford Nanopore Technologies Plc has traded between $1.27 and $3.19.

How much debt does Oxford Nanopore Technologies Plc have?

As of the most recent reporting period, Oxford Nanopore Technologies Plc reported total debt of £55.82M.

How much cash does Oxford Nanopore Technologies Plc have on hand?

Oxford Nanopore Technologies Plc reported £243.59M in cash and cash equivalents in its most recent financial results.

What is Oxford Nanopore Technologies Plc’s dividend yield?

Oxford Nanopore Technologies Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services